Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126241631 | 12624163 | 1 | I | 20160801 | 20160805 | 20160805 | EXP | JP-ROCHE-1806026 | ROCHE | MORIO K, MINAMI T, SOZU T, NIKI K, KIJIMA T AND UEJIMA E WEIGHT LOSS ASSOCIATED WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH ADVANCED LUNG CANCER. CHEMOTHERAPY 2016 FEB 25;61(5):256-261. | 0.00 | Y | 0.00000 | 20160805 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126241631 | 12624163 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 125085 | ||||||||||
| 126241631 | 12624163 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 3 | SS | PEMETREXED | PEMETREXED | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 4 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 5 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 6 | SS | NAB-PACLITAXEL | PACLITAXEL | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 7 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 8 | SS | TEGAFUR | TEGAFUR | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 9 | SS | GIMERACIL | GIMERACIL | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 10 | SS | OTERACIL POTASSIUM | OTERACIL POTASSIUM | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 11 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | 0 | ||||||||||
| 126241631 | 12624163 | 12 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126241631 | 12624163 | 1 | Lung neoplasm malignant |
| 126241631 | 12624163 | 2 | Lung neoplasm malignant |
| 126241631 | 12624163 | 3 | Lung neoplasm malignant |
| 126241631 | 12624163 | 4 | Lung neoplasm malignant |
| 126241631 | 12624163 | 5 | Lung neoplasm malignant |
| 126241631 | 12624163 | 6 | Lung neoplasm malignant |
| 126241631 | 12624163 | 7 | Lung neoplasm malignant |
| 126241631 | 12624163 | 8 | Lung neoplasm malignant |
| 126241631 | 12624163 | 9 | Lung neoplasm malignant |
| 126241631 | 12624163 | 10 | Lung neoplasm malignant |
| 126241631 | 12624163 | 11 | Lung neoplasm malignant |
| 126241631 | 12624163 | 12 | Lung neoplasm malignant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126241631 | 12624163 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126241631 | 12624163 | Anaemia | |
| 126241631 | 12624163 | Decreased appetite | |
| 126241631 | 12624163 | Glomerular filtration rate abnormal | |
| 126241631 | 12624163 | Hypoalbuminaemia | |
| 126241631 | 12624163 | Leukopenia | |
| 126241631 | 12624163 | Nausea | |
| 126241631 | 12624163 | Neutropenia | |
| 126241631 | 12624163 | Thrombocytopenia | |
| 126241631 | 12624163 | Vomiting | |
| 126241631 | 12624163 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |